Healthcare & Life Sciences
Opthea
Australiawww.opthea.com/
Opthea is a Healthcare & Life Sciences startup based in Australia, most recent round Series B, 3 tracked investors.
activeseries-b
series-b
Stage
3
Investors
About Opthea
Opthea is a startup based in Australia. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Opthea is a clinical-stage biopharmaceutical company focused on developing novel therapies to treat retinal eye diseases, particularly wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). The company is advancing OPT-302, a VEGF-C/D 'trap' designed to improve visual outcomes when combined with existing treatments.
Explore Opthea's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.